Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Antonella Miglietta"'
Autor:
Erica Novo, Gianmarco Villano, Cristian Turato, Stefania Cannito, Claudia Paternostro, Chiara Busletta, Alessandra Biasiolo, Santina Quarta, Elisabetta Morello, Claudia Bocca, Antonella Miglietta, Ezio David, Salvatore Sutti, Mario Plebani, Emanuele Albano, Maurizio Parola, Patrizia Pontisso
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Abstract SerpinB3 is a hypoxia- and hypoxia-inducible factor-2α-dependent cystein protease inhibitor that is up-regulated in hepatocellular carcinoma and in parenchymal cells during chronic liver diseases (CLD). SerpinB3 up-regulation in CLD patient
Externí odkaz:
https://doaj.org/article/c74e478e1eb44cac816dd0dfb0e444b3
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 1, Iss 5, Pp 477-488 (2015)
Pathologic angiogenesis appears to be intrinsically associated with the fibrogenic progression of chronic liver diseases, which eventually leads to the development of cirrhosis and related complications, including hepatocellular carcinoma. Several la
Externí odkaz:
https://doaj.org/article/a0faecc3dcd640528a3bf43cdbce1722
Autor:
Salvatore Sutti, Alessandra Biasiolo, Santina Quarta, Emanuele Albano, Claudia Bocca, Erica Novo, Maurizio Parola, Mario Plebani, Chiara Busletta, E. Morello, Cristian Turato, Antonella Miglietta, Patrizia Pontisso, Claudia Paternostro, G. Villano, Ezio David, Stefania Cannito
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
SerpinB3 is a hypoxia- and hypoxia-inducible factor-2α-dependent cystein protease inhibitor that is up-regulated in hepatocellular carcinoma and in parenchymal cells during chronic liver diseases (CLD). SerpinB3 up-regulation in CLD patients has bee
Publikováno v:
British Journal of Nutrition. 96:22-27
Conjugated linoleic acid (CLA) has protective properties in breast cancer. Here, we studied the mechanisms underlying the effects of CLA on MCF-7 breast cancer cell proliferation, especially in correlation with the involvement of the extracellular si
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology
Pathologic angiogenesis appears to be intrinsically associated with the fibrogenic progression of chronic liver diseases, which eventually leads to the development of cirrhosis and related complications, including hepatocellular carcinoma. Several la
Publikováno v:
Cancer Letters. 209:139-145
Insulin regulates metabolism through homologous receptor tyrosine kinases, and plays a role in proliferation of breast cancer cells. Our research studied whether insulin, administered separately or in combination with paclitaxel, interferes with pacl
Publikováno v:
Cancer Chemotherapy and Pharmacology. 51:67-74
Purpose. The biological activities of macrocyclic jatrophane polyesters 1–3 from the Sardinian endemism Euphorbia semiperfoliata Viv. have not been evaluated in depth. We investigated the microtubule-interacting and antiproliferative activities of
Publikováno v:
Chemico-Biological Interactions. 139:283-299
We have compared the nature of interaction of certain taxanes with microtubular protein, and the mechanism of action underlying cytotoxic activity. Taxanes induced tubulin assembly in vitro, but only taxanes bearing side chain were capable of inducin
Autor:
Claudia Paternostro, Antonella Miglietta, Maurizio Parola, Claudia Bocca, Erica Novo, Stefania Cannito
Liver fibrogenesis is a dynamic and highly integrated molecular, tissue and cellular process, potentially reversible, that drives the progression of chronic liver diseases (CLD) towards liver cirrhosis and hepatic failure. Hepatic myofibroblasts (MFs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6351525a8885b8868dfd62499f397ea2
http://hdl.handle.net/2318/143288
http://hdl.handle.net/2318/143288
Autor:
Stefania, Cannito, Claudia, Paternostro, Chiara, Busletta, Claudia, Bocca, Sebastiano, Colombatto, Antonella, Miglietta, Erica, Novo, Maurizio, Parola
Fibrogenic progression of chronic liver diseases (CLDs) towards the end-point of cirrhosis is currently regarded, whatever the aetiology, as a dynamic and highly integrated cellular response to chronic liver injury. Liver fibrogenesis (i.e., the proc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fa5ed875cbec457e669f9289f7ca2087
http://hdl.handle.net/2318/143280
http://hdl.handle.net/2318/143280